News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
IDEXX Laboratories' stock performance remains tied to strong demand for its veterinary diagnostics, instruments, and software. The company reported significant financial growth in fiscal 2025, with revenues reaching $3.97 billion and net income at $1.08 billion, alongside improved diluted EPS of $13.01. This consistent …
Sharemaestro market context Price above Trend Line 52 weeks -13.7% · Next-week setup negative 32.7%IDEXX Laboratories Inc. (IDXX) stock fell 1.50% on Friday, closing at $567.44, amidst a general market downturn where the S&P 500 Index and Dow Jones Industrial Average also declined. This dip ended a two-day winning streak for the company's shares. The underperformance was noted …
IDEXX Laboratories stock is trading near record levels, driven by strong demand for companion animal diagnostics and software services for veterinary practices. The company reported double-digit revenue growth and improved operating margins, primarily from its companion animal group, which accounts for over 85% of …
Stifel's recent commentary suggests that IDEXX Laboratories (IDXX) could be significantly undervalued, with an estimated fair value of $709.14 compared to its current price of $576.07, representing a 19% undervaluation. This assessment is based on improving confidence among U.S. veterinarians regarding companion animal health …
Search by ticker symbol or company name and select a result to open its chart.